3 Things Standing Between MannKind Corporation and Greatness

Fool.com Headlines http://ift.tt/1xdujoE MannKind's revolutionary inhaled diabetes drug, Afrezza, will soon be on pharmacy shelves, but these three hurdles could stand in the way of MannKind's stock heading higher.